University of Liverpool: Clinical Trial Gives Hope of New Treatment for Aggressive Eye Cancer
November 03, 2021
November 03, 2021
LIVERPOOL, England, Nov. 3 (TNSJou) -- The University of Liverpool issued the following news release:
A potentially game-changing trial involving University of Liverpool researchers has shown how an immunotherapy drug can prolong the life of patients with an aggressive form of eye cancer.
The clinical research trial, taking place at The Clatterbridge Cancer Centre, has for the first time shown that a new treatment can improve survival rates in people with secondary uvea . . .
A potentially game-changing trial involving University of Liverpool researchers has shown how an immunotherapy drug can prolong the life of patients with an aggressive form of eye cancer.
The clinical research trial, taking place at The Clatterbridge Cancer Centre, has for the first time shown that a new treatment can improve survival rates in people with secondary uvea . . .